Electronic Consent of Numerous Subjects Employing Novel Techniques Trial
NCT ID: NCT02799407
Last Updated: 2024-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2018-11-01
2019-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of Patient Centered Virtual Multimedia Interactive Informed Consent Tool to Improve Patient Comprehension and Consent
NCT02537886
Comparative Study of Non-contact Tonometers for Intraocular Pressure and Corneal Cell Thickness Measurements
NCT02138279
Rapid Prototyping Models for Patient Education
NCT02718807
Evaluation of a Novel Method of Contrast Volume Quantification - AVERT PLUS 2.0
NCT02578173
Detection of Minor Changes in Fluid Volume or Tonicity in Healthy Volunteers.
NCT04937491
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Traditional Long Form Consent
Participants will receive the traditional long-form consent form.
No interventions assigned to this group
ResearchKit Consent
Participants will receive the Apple ResearchKit consent form.
ResearchKit Consent
Multi-tiered consent form using the Apple ResearchKit Platform.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ResearchKit Consent
Multi-tiered consent form using the Apple ResearchKit Platform.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to read and understand study materials which are presented in English
* Owns or has access to a smartphone or other smart device such as a tablet or iPod
Exclusion Criteria
* Employed in a research position, clinical care position, or position which has regular exposure to clinical research
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Tanaka, MD
Role: PRINCIPAL_INVESTIGATOR
Duke Health
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00070430
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.